Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8950 USD | +0.45% |
|
-0.78% | -6.11% |
Projected Income Statement: Imunon, Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 0.5 | 0.5 | 0.5 | 0.5 | - | - | - | - |
Change | - | 0% | 0% | 0% | -100% | - | - | - |
EBITDA | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - |
EBIT 1 | -20.56 | -18.49 | -21.01 | -24.92 | -21.03 | -20.73 | -27.44 | -36.48 |
Change | - | -10.11% | 13.64% | 18.64% | -15.62% | 1.43% | -32.38% | -32.93% |
Interest Paid | -1.393 | -1.292 | -0.5699 | -5.029 | -0.1971 | - | - | - |
Earnings before Tax (EBT) 1 | -18.67 | -23.33 | -22.15 | -37.46 | -20.8 | -20.48 | -27.42 | -36.87 |
Change | - | 24.97% | -5.04% | 69.12% | -44.49% | 1.52% | -33.89% | -34.46% |
Net income 1 | -16.85 | -21.48 | -20.77 | -35.9 | -19.52 | -20.48 | -27.42 | -36.87 |
Change | - | 27.49% | -3.33% | 72.84% | -45.64% | -4.93% | -33.89% | -34.46% |
Announcement Date | 3/25/20 | 3/19/21 | 3/31/22 | 3/30/23 | 3/28/24 | - | - | - |
Forecast Balance Sheet: Imunon, Inc.
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - |
Announcement Date | 3/25/20 | 3/19/21 | 3/31/22 | 3/30/23 | 3/28/24 | - | - | - |
Cash Flow Forecast: Imunon, Inc.
Fiscal Period: December | 2024 | 2025 | 2026 |
---|---|---|---|
CAPEX 1 | - | - | - |
Change | - | - | - |
Free Cash Flow (FCF) 1 | -4 | -33 | -42.35 |
Change | - | 725% | 28.33% |
Announcement Date | - | - | - |
Forecast Financial Ratios: Imunon, Inc.
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|---|
Profitability | |||||||||
EBITDA Margin (%) | - | - | - | - | - | - | - | - | - |
EBIT Margin (%) | - | -4,113% | -3,697.2% | -4,201.4% | -4,984.4% | - | - | - | - |
EBT Margin (%) | - | -3,733.6% | -4,665.8% | -4,430.6% | -7,493% | - | - | - | - |
Net margin (%) | - | -3,370.4% | -4,296.8% | -4,153.8% | -7,179.6% | - | - | - | - |
FCF margin (%) | - | - | - | - | - | - | - | - | - |
FCF / Net Income (%) | - | - | - | - | - | - | 19.53% | 120.36% | 114.87% |
Profitability | |||||||||
ROA | -27.9% | -30.2% | -30.48% | -23.54% | -26.39% | -39.89% | - | - | - |
ROE | -49.97% | -95.15% | -129.54% | -55.83% | -84.34% | -91.37% | - | - | - |
Financial Health | |||||||||
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - | - |
Debt / Free cash flow | - | - | - | - | - | - | - | - | - |
Capital Intensity | |||||||||
CAPEX / Current Assets (%) | - | - | - | - | - | - | - | - | - |
CAPEX / EBITDA (%) | - | - | - | - | - | - | - | - | - |
CAPEX / FCF (%) | - | - | - | - | - | - | - | - | - |
Items per share | |||||||||
Cash flow per share 1 | - | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - | - |
Dividend per Share 1 | - | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - | - |
Book Value Per Share 1 | - | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - | - |
EPS 1 | - | -11.55 | -10.05 | -3.83 | -5.03 | -2.16 | -1.7 | -1.035 | -0.7267 |
Change | - | - | -12.99% | -61.89% | 31.33% | -57.06% | -21.3% | -39.12% | -29.79% |
Nbr of stocks (in thousands) | - | 1,517 | 2,495 | 5,771 | 7,434 | 9,399 | 14,501 | 14,501 | 14,501 |
Announcement Date | - | 3/25/20 | 3/19/21 | 3/31/22 | 3/30/23 | 3/28/24 | - | - | - |
2024 * | 2025 * | |
---|---|---|
P/E ratio | -0.52x | -0.86x |
PBR | - | - |
EV / Sales | - | - |
Yield | - | - |
EPS & Dividend
Year-on-year evolution of the PER

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IMNN Stock
- Financials Imunon, Inc.